Aptinyx Inc reported $24.29M in Loan Capital for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Loan Capital Change
Acadia Pharmaceuticals ACAD:US $ 0M 0M
Acorda Therapeutics ACOR:US $ 182.44M 3.77M
Biogen BIIB:US $ 6275.7M 1.7M
Cara Therapeutics CARA:US $ 0 0
Daiichi Sankyo 4568:JP Y 143067M 94M
Halozyme Therapeutics HALO:US $ 788.1M 0.84M
IONIS PHARMACEUT IONS:US $ 1247.93M 19.91M
Novartis NOVN:VX SF 24373M 150M
Ultragenyx Pharmaceutical RARE:US $ 0M 0.41M